查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1928641

翻新C型臂市場按產品類型、檢測類型、技術、應用和最終用戶分類，全球預測（2026-2032）

Refurbished C-Arms Market by Product Type, Detector Type, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，翻新 C 型臂市場價值將達到 2.4533 億美元，到 2026 年將成長至 2.6728 億美元，到 2032 年將達到 4.1275 億美元，複合年成長率為 7.71%。

關鍵市場統計數據
基準年 2025 2.4533億美元
預計年份：2026年 2.6728億美元
預測年份 2032 4.1275億美元
複合年成長率 (%) 7.71%

將翻新的C型臂作為臨床有效且資本效率高的診斷影像設備進行策略性應用，正在重塑採購流程和臨床工作流程。

在現代醫療環境中，翻新的C型臂系統正日益被視為平衡臨床需求和資金管理的有效解決方案。這些系統可在廣泛的臨床領域提供診斷和治療影像功能，並且在預算限制、快速部署需求和資源最佳化至關重要的情況下，經常被用作新設備的理想替代方案。因此，醫院、門診手術中心、診所和診斷中心正在重新思考其診斷影像設備的採購路徑和生命週期管理。

本文簡要概述了正在推動翻新C臂生態系統專業化並轉變需求促進因素的變革性技術、臨床和採購變化。

受技術成熟、臨床實踐變化和採購理念演變的驅動，翻新C型臂的市場環境正在經歷一場變革。隨著數位影像工作流程的整合、檢測器效能的提升以及服務通訊協定的改進，翻新產品與新產品之間的功能差距正在縮小。因此，臨床團隊和採購負責人擴大評估翻新產品，尤其是經過檢驗測試、零件更換和軟體校準的產品，以用於各種常規和複雜的手術。

分析關稅制度變化對翻新C臂籌資策略、供應鏈韌性及總成本估算的影響

關稅政策和進口法規正直接影響翻新醫療設備的經濟效益，並重塑依賴跨國翻新供應鏈的醫療服務提供者的採購策略。關稅制度的變化可能會影響翻新系統和備件的到岸成本，改變供應商的路線選擇，並促使區域翻新中心和本地夥伴關係關係的建立，從而降低進口關稅風險。因此，醫療採購商和服務供應商正在透過供應商網路多元化和評估替代採購模式（包括與當地翻新合作夥伴和簽訂當地服務合約）來適應變化。

關鍵的細分洞察，將產品類型、臨床應用、用戶環境、檢測器選擇和技術平台與採購和營運優先順序相匹配。

細分市場提供了一個系統性的觀點，幫助我們了解翻新C型臂在哪些方面能發揮最大的營運和臨床價值。根據產品類型，醫療機構將固定式系統（提供穩定、高通量的成像室）與移動式設備（優先考慮便攜性和靈活的房間佈置）區分開來。這種區分會影響採購決策，因為醫療機構需要在處理容量要求和手術種類之間取得平衡。根據應用領域，翻新C型臂被廣泛應用於各個專科，包括循環系統、消化病學、普通外科、神經病學、整形外科、疼痛管理和泌尿系統。循環系統可進一步細分為診斷性和介入性心臟病學，而一般外科則可區分微創手術和開放性手術。這些臨床差異決定了影像品質要求、檢測器偏好和服務水準預期。

從全面的區域觀點出發，深入分析美洲、歐洲、中東和非洲以及亞太地區的趨勢如何推動需求、服務和籌資策略的差異化。

區域趨勢深刻影響著翻新C臂機的應用模式、服務生態系和供應商策略。在美洲，成熟的醫療網路和完善的次市場孕育了強大的分銷管道和完善的服務基礎設施，從而實現了快速部署和可預測的維護週期。隨著醫療服務從都市區三級醫療中心向鄉村醫療機構轉移，該地區的買家需要在成本控制與手術範圍和影像品質之間尋求平衡。

競爭性評估清楚地表明，技術嚴謹性、服務品質和策略​​合作夥伴關係如何使翻新C臂供應商脫穎而出，並推動醫療機構採用這些設備。

翻新C型臂市場的競爭格局由專業翻新商、認證服務供應商、獨立再製造商和臨床設備經銷商組成。領先企業憑藉嚴謹的技術、透明的檢驗流程和完善的售後支援脫穎而出。那些投資於標準化測試通訊協定、可追溯的零件更換和認證服務技術人員的公司，已在醫院和診斷中心獲得了較高的機構認可度和回頭客。

針對醫療領導者，就翻新C型臂引入檢驗標準化、供應鏈多元化以及加強與臨床工程部門的合作等方面，提出切實有效的建議。

產業領導者應採取多管齊下的策略，整合技術檢驗、供應鏈韌性和相關人員協作，以充分利用翻新C型臂的市場機會。首先，醫療負責人應制定正式的驗收標準和標準化測試通訊協定，在部署前檢驗影像品質、機械完整性和軟體性能。將這些標準納入採購合約可以減少歧義，並協調臨床團隊和供應商之間的預期。

採用透明的混合方法調查方法，結合關鍵相關人員對話、技術檢驗審查和資料三角測量，以獲得可操作的見解。

本分析整合了混合方法研究的成果，該方法結合了對技術文獻、監管指南和檢驗的翻新標準的系統性回顧，以及與臨床工程師、採購負責人、翻新專家和診斷影像醫師的直接訪談。二手資料提供了技術趨勢、檢測器性能特徵和法規結構的背景資訊，而直接訪談則提供了關於採購週期、安裝挑戰和服務預期等方面的運營觀點。

綜合研究結果表明，當管治、標準和供應彈性協調一致時，翻新的 C 型臂可以作為具有戰略意義且永續的診斷成像資產。

翻新C型臂是臨床能力與資本管理相結合的實用方案，具有大幅擴展不同醫療機構介入和診斷影像檢查覆蓋範圍的潛力。翻新標準的提升、臨床認可的提高以及靈活的採購模式，使翻新系統成為現代成像策略中不可或缺的組成部分。然而，要充分發揮這一潛力，需要嚴格的檢驗通訊協定、穩健的供應鏈以及臨床和工程相關人員的緊密合作，以確保性能穩定並符合監管要求。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依產品類型分類的翻新C型臂市場

  • 固定的
  • 移動的

9. 按檢測器類型分類的翻新C型臂市場

  • 平板檢測器
  • 影像增強器

第10章 按技術分類的翻新C臂市場

  • 模擬
  • 數位的

第11章 按應用分類的翻新C型臂市場

  • 心臟病學
    • 診斷心臟病學
    • 介入性心臟病學
  • 胃腸病學
  • 一般外科
    • 微創手術
    • 開放性手術
  • 神經病學
  • 整形外科
  • 疼痛管理
  • 泌尿系統

第12章 翻新C臂市場（依最終用戶分類）

  • 門診手術中心
  • 診所
  • 診斷中心
  • 醫院
    • 公立醫院
    • 私立醫院

第13章 各地區翻新C臂市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 翻新C臂市場（依團體分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國翻新C型臂市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國翻新C型臂市場

第17章 中國翻新C臂市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Agito Medical A/S
  • Avante Health Solutions, Inc.
  • Block Imaging, Inc.
  • Canon Medical Systems Corporation
  • Carestream Health, Inc.
  • EverX Pty Ltd
  • Fair Medical Co., Ltd.
  • Fujifilm Healthcare
  • Future Health Concepts, Inc.
  • GE Healthcare, Inc.
  • Hilditch Group Ltd.
  • Hitachi Medical Systems
  • Integrity Medical Systems, Inc.
  • Koninklijke Philips NV
  • Master Medical Equipment, LLC
  • Nationwide Imaging Services, Inc.
  • Pacific Healthcare Imaging, LLC
  • Radiology Oncology Systems, Inc.（ROS）
  • Radon Medical Imaging LLC
  • Siemens Healthineers AG
  • Soma Technology, Inc.
  • Ultra Imaging Solutions, LLC
  • US Med-Equip, Inc.
  • Venture Medical ReQuip, Inc.
  • Whittemore Enterprises, Inc.
Product Code: MRR-92740D85F086

The Refurbished C-Arms Market was valued at USD 245.33 million in 2025 and is projected to grow to USD 267.28 million in 2026, with a CAGR of 7.71%, reaching USD 412.75 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 245.33 million
Estimated Year [2026] USD 267.28 million
Forecast Year [2032] USD 412.75 million
CAGR (%) 7.71%

A strategic introduction that frames refurbished C-arms as clinically effective, capital-efficient imaging assets reshaping procurement and clinical workflows

Refurbished C-arm systems are increasingly recognized as pragmatic solutions that reconcile clinical imperatives with capital stewardship in contemporary healthcare environments. These systems offer diagnostic and interventional imaging capabilities that extend across a wide array of procedural disciplines, and they frequently serve as pragmatic alternatives to new equipment where budgetary constraints, rapid deployment needs, or resource optimization are paramount. As a result, hospitals, ambulatory surgical centers, clinics, and diagnostic centers are reassessing procurement pathways and lifecycle management for imaging assets.

In this context, refurbished C-arms present a confluence of clinical utility, technological compatibility, and procurement flexibility. They enable institutions to maintain procedural throughput and imaging quality while deferring or reducing capital expenditure. Moreover, refurbishment strategies often include preventative maintenance agreements, parts replacement, and software updates that extend operational lifespan and facilitate interoperability with other imaging and record systems. This introductory framing underscores the practical value proposition of refurbished C-arms and sets the stage for a deeper exploration of market dynamics, regulatory influences, and operational considerations that influence adoption across diverse clinical settings.

Consequently, decision-makers should view refurbished C-arms not merely as cost-reduction instruments but as strategic enablers of care continuity and capital efficiency. The remainder of this executive summary elaborates on transformative shifts, tariff implications, segmentation insights, regional differentials, competitive dynamics, and clear recommendations for leaders pursuing sustainable imaging strategies.

A concise synthesis of transformative technological, clinical, and procurement shifts that are professionalizing the refurbished C-arm ecosystem and altering demand drivers

The landscape for refurbished C-arms is undergoing transformative shifts driven by technological maturation, changing clinical practices, and evolving procurement philosophies. Increasingly, integration of digital imaging workflows, enhanced detector performance, and improved servicing protocols have narrowed the functional gap between refurbished and new systems. As a result, clinical teams and procurement leaders are more willing to evaluate refurbished equipment for routine and complex procedures, particularly when refurbishment includes validated testing, component replacement, and software calibration.

At the same time, clinical workload patterns and the decentralization of care are reshaping demand. Ambulatory surgical centers and outpatient interventional suites are expanding procedural scope, creating new avenues for refurbished equipment deployment. In parallel, hospitals are prioritizing asset flexibility and rapid redeployment across departments to manage episodic surges in demand. These shifts favor refurbishers that can deliver rapid turnkey installations, validated reconditioning, and service agreements that mirror the reliability expectations of larger institutions.

Additionally, regulatory scrutiny and quality assurance expectations have risen, prompting vendors and refurbishers to adopt standardized validation protocols and traceable service histories. This convergence of technical, clinical, and regulatory factors is catalyzing a professionalization of the refurbishment ecosystem and creating differentiated value propositions for suppliers that combine technical rigor with cost-conscious delivery models.

An analysis of how evolving tariff regimes are reshaping procurement strategies, supply chain resilience, and total cost considerations for refurbished C-arm acquisition

Tariff policies and import regulations exert an immediate influence on the economics of refurbished imaging equipment, reshaping procurement calculus for healthcare providers that rely on cross-border refurbishment supply chains. Changes in tariff regimes can affect the landed cost of refurbished systems and spare parts, alter vendor routing decisions, and incentivize regional refurbishment hubs or local partnerships that reduce exposure to import duties. Healthcare buyers and service providers are therefore adapting by diversifying supplier networks and evaluating alternative sourcing models, including domestic refurbishment partners and in-country service agreements.

In response to tariff-driven cost variability, procurement teams are prioritizing contractual flexibility and supply chain resilience. This includes negotiating fixed-price service contracts, exploring consignment models for critical spare parts, and establishing multi-vendor frameworks to mitigate single-source dependencies. These tactical adjustments help institutions stabilize operational budgets and preserve procedural capacity despite potential cost shifts tied to tariff actions.

Moreover, tariffs catalyze broader strategic considerations, such as evaluating the total cost of ownership beyond initial purchase price. Organizations are increasingly weighing service quality, warranty terms, availability of trained biomedical staff, and the logistical complexity of redeployment when making procurement decisions. As a result, tariff changes do not simply affect price-they influence competitive positioning, vendor selection criteria, and the development of localized service capabilities that support long-term sustainability.

Key segmentation insights that align product types, clinical applications, user settings, detector choices, and technology platforms with procurement and operational priorities

Segmentation offers a structured lens for understanding where refurbished C-arms deliver the most operational and clinical value. Based on product type, institutions differentiate between fixed systems that provide stable, high-throughput imaging suites and mobile units that prioritize portability and flexible room deployment. This distinction influences procurement decisions as facilities balance throughput needs against space constraints and procedural diversity. Based on application, refurbished C-arms serve a wide span of specialties including cardiology, gastroenterology, general surgery, neurology, orthopedics, pain management, and urology, with cardiology further dividing into diagnostic and interventional use cases while general surgery differentiates between minimally invasive and open procedures; these clinical nuances dictate image quality requirements, detector preferences, and service-level expectations.

Based on end user, deployment contexts range from ambulatory surgical centers and clinics to diagnostic centers and hospitals, with hospitals further categorized into government and private facilities that exhibit distinct procurement cycles and budgetary frameworks. The ownership and governance model of the end user often informs warranty tolerance, expected uptime, and acceptance testing protocols. Based on detector type, choices between flat panel detectors and image intensifiers affect image resolution, dose management, and procedural suitability, while technology classification into analog and digital systems shapes integration complexity with modern PACS and reporting workflows. By interpreting these segmentation dimensions together, leaders can match refurbished configurations to clinical needs, operational constraints, and long-term service strategies to maximize both clinical outcomes and asset utilization.

A comprehensive regional perspective detailing how Americas, Europe Middle East & Africa, and Asia-Pacific dynamics drive differentiated demand, servicing, and procurement tactics

Regional dynamics profoundly influence adoption patterns, service ecosystems, and vendor strategies for refurbished C-arms. In the Americas, established healthcare networks and mature secondary markets favor robust redistributor channels and comprehensive service infrastructures, enabling rapid deployment and predictable maintenance cycles. Transitioning from urban tertiary centers to rural facilities, buyers in this region balance cost management with expectations for procedural range and imaging quality.

Across Europe, Middle East & Africa, regulatory heterogeneity and variable healthcare funding models create differentiated adoption profiles. Western European facilities tend to emphasize compliance and standardized refurbishment documentation, while markets in the Middle East and Africa often prioritize rapid availability and adaptable financing solutions. As a result, successful suppliers tailor certification and service packages to meet diverse regulatory and operational requirements across subregions.

In Asia-Pacific, rapid investment in outpatient procedural capacity and a broad spectrum of healthcare facility types-from advanced metropolitan hospitals to resource-constrained regional clinics-drives demand for both high-end and cost-efficient refurbished systems. Networked procurement strategies and regional refurbishment hubs emerge as effective mechanisms to support fast turnaround, parts availability, and localized technical support. Collectively, these regional characteristics shape how refurbishers allocate inventory, design service offerings, and partner with clinical stakeholders to ensure reliable performance across varied geographies.

An incisive competitive assessment highlighting how technical rigor, service excellence, and strategic partnerships differentiate refurbished C-arm providers and drive institutional adoption

Competitive dynamics in the refurbished C-arm space reflect a blend of specialized refurbishers, authorized service providers, independent remanufacturers, and clinical equipment distributors. Leading players differentiate on technical rigor, transparent validation processes, and the breadth of aftermarket support. Those that invest in standardized testing protocols, traceable component replacement, and certified service technicians achieve higher institutional acceptance and repeat business among hospitals and diagnostic centers.

Moreover, strategic partnerships between refurbishers and hospital biomedical engineering teams are becoming increasingly important. These collaborations expedite acceptance testing, streamline installations, and align preventive maintenance schedules with clinical workflows. Vendors that provide robust service-level agreements, remote diagnostic capabilities, and modular upgrade paths can convert initial transactions into long-term service relationships. In addition, companies that offer tailored financing solutions and short-term leasing options enable customers to trial refurbished systems with reduced capital exposure.

Finally, differentiators such as rapid parts availability, documented compliance, and demonstrable uptime metrics influence procurement committees that evaluate risk and clinical continuity. As clinical teams demand consistent imaging performance, firms that can combine reliability with cost-effectiveness will sustain competitive advantage and expand their footprint across multiple end-user segments.

Practical, high-impact recommendations for healthcare leaders to standardize validation, diversify supply chains, and strengthen clinical-engineering collaboration for refurbished C-arm adoption

Industry leaders should adopt a multi-pronged strategy that integrates technical validation, supply chain resilience, and stakeholder alignment to capitalize on refurbished C-arm opportunities. First, institutional buyers must formalize acceptance criteria and standardized testing protocols that validate image quality, mechanical integrity, and software performance prior to commissioning. Embedding these criteria in procurement contracts reduces ambiguity and aligns expectations between clinical teams and suppliers.

Second, organizations should diversify sourcing channels and cultivate local service partnerships to mitigate geopolitical and tariff-related risks. Establishing regional refurbishment hubs or authorized service agreements ensures faster turnaround for parts and repairs, and enhances continuity of care. Third, clinical and biomedical engineering teams should collaborate early in the procurement cycle to define performance tolerances and integration requirements with PACS and electronic health systems. This cross-functional coordination reduces installation friction and shortens time-to-first-use.

Finally, procurement leaders should require transparent documentation of refurbishment processes, component provenance, and warranty terms as part of vendor evaluation. These contractual safeguards and performance metrics enable clearer accountability and support long-term lifecycle planning. By implementing these measures, stakeholders can harness the clinical and operational advantages of refurbished C-arms while managing risk and preserving quality of care.

A transparent, mixed-methods research methodology combining primary stakeholder engagement, technical validation review, and data triangulation to produce actionable findings

This analysis synthesizes insights derived from a mixed-methods research approach that combines systematic review of technical literature, regulatory guidance, and validated refurbishment standards with primary engagement of clinical engineers, procurement professionals, refurbishing specialists, and imaging clinicians. Secondary sources provided context on technological trends, detector performance characteristics, and regulatory frameworks, while primary interviews offered operational perspectives on procurement cycles, installation challenges, and service expectations.

Data triangulation ensured consistency across qualitative inputs and technical documentation, and thematic coding was applied to interview transcripts to surface recurring priorities such as uptime, documentation rigor, and parts availability. Case studies of facility-level deployments informed practical considerations for installation, training, and acceptance testing. In addition, supplier capability assessments focused on validation protocols, warranty structure, spare-parts logistics, and remote diagnostic capabilities.

Throughout, the methodology emphasized reproducibility and transparency by documenting inclusion criteria for sources, interview protocols, and the analytical framework used to align segmentation dimensions with regional and competitive factors. This approach supports credible, actionable findings that reflect both technical realities and operational constraints relevant to refurbished C-arm procurement and deployment.

A conclusive synthesis that positions refurbished C-arms as strategic, sustainable imaging assets when governance, standards, and supply resilience are aligned

Refurbished C-arms represent a pragmatic intersection of clinical capability and capital stewardship that can meaningfully expand access to interventional and diagnostic imaging across diverse care settings. The convergence of improved refurbishment standards, greater clinical acceptance, and adaptive procurement models positions refurbished systems as durable components of modern imaging strategies. Nevertheless, realizing this potential requires disciplined validation protocols, resilient supply chains, and tight collaboration between clinical and engineering stakeholders to ensure consistent performance and regulatory compliance.

Decision-makers should therefore treat refurbishment as a strategic element of asset management, integrating it into lifecycle planning, maintenance budgeting, and procedural deployment roadmaps. By doing so, organizations can preserve clinical throughput, support expanding outpatient procedural volumes, and respond agilely to shifting demand patterns. In summary, refurbished C-arms provide an actionable pathway to balance fiscal responsibility with clinical excellence when stakeholders adopt rigorous standards, diversify sourcing, and prioritize service continuity.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Refurbished C-Arms Market, by Product Type

  • 8.1. Fixed
  • 8.2. Mobile

9. Refurbished C-Arms Market, by Detector Type

  • 9.1. Flat Panel Detector
  • 9.2. Image Intensifier

10. Refurbished C-Arms Market, by Technology

  • 10.1. Analog
  • 10.2. Digital

11. Refurbished C-Arms Market, by Application

  • 11.1. Cardiology
    • 11.1.1. Diagnostic Cardiology
    • 11.1.2. Interventional Cardiology
  • 11.2. Gastroenterology
  • 11.3. General Surgery
    • 11.3.1. Minimally Invasive Surgery
    • 11.3.2. Open Surgery
  • 11.4. Neurology
  • 11.5. Orthopedics
  • 11.6. Pain Management
  • 11.7. Urology

12. Refurbished C-Arms Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Clinics
  • 12.3. Diagnostic Centers
  • 12.4. Hospitals
    • 12.4.1. Government Hospitals
    • 12.4.2. Private Hospitals

13. Refurbished C-Arms Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Refurbished C-Arms Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Refurbished C-Arms Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Refurbished C-Arms Market

17. China Refurbished C-Arms Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Agito Medical A/S
  • 18.6. Avante Health Solutions, Inc.
  • 18.7. Block Imaging, Inc.
  • 18.8. Canon Medical Systems Corporation
  • 18.9. Carestream Health, Inc.
  • 18.10. EverX Pty Ltd
  • 18.11. Fair Medical Co., Ltd.
  • 18.12. Fujifilm Healthcare
  • 18.13. Future Health Concepts, Inc.
  • 18.14. GE Healthcare, Inc.
  • 18.15. Hilditch Group Ltd.
  • 18.16. Hitachi Medical Systems
  • 18.17. Integrity Medical Systems, Inc.
  • 18.18. Koninklijke Philips N.V.
  • 18.19. Master Medical Equipment, LLC
  • 18.20. Nationwide Imaging Services, Inc.
  • 18.21. Pacific Healthcare Imaging, LLC
  • 18.22. Radiology Oncology Systems, Inc. (ROS)
  • 18.23. Radon Medical Imaging LLC
  • 18.24. Siemens Healthineers AG
  • 18.25. Soma Technology, Inc.
  • 18.26. Ultra Imaging Solutions, LLC
  • 18.27. US Med-Equip, Inc.
  • 18.28. Venture Medical ReQuip, Inc.
  • 18.29. Whittemore Enterprises, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL REFURBISHED C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL REFURBISHED C-ARMS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL REFURBISHED C-ARMS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES REFURBISHED C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA REFURBISHED C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL REFURBISHED C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY FIXED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY FIXED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY FIXED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY MOBILE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY MOBILE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY MOBILE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY FLAT PANEL DETECTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY FLAT PANEL DETECTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY FLAT PANEL DETECTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY IMAGE INTENSIFIER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY ANALOG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY ANALOG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY ANALOG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY DIGITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY DIGITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY DIGITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY DIAGNOSTIC CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY DIAGNOSTIC CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY DIAGNOSTIC CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY INTERVENTIONAL CARDIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY INTERVENTIONAL CARDIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY INTERVENTIONAL CARDIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY GASTROENTEROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY GASTROENTEROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY MINIMALLY INVASIVE SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY OPEN SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY OPEN SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY ORTHOPEDICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY ORTHOPEDICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY UROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY GOVERNMENT HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY GOVERNMENT HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS REFURBISHED C-ARMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS REFURBISHED C-ARMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS REFURBISHED C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS REFURBISHED C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS REFURBISHED C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS REFURBISHED C-ARMS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS REFURBISHED C-ARMS MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS REFURBISHED C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS REFURBISHED C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA REFURBISHED C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA REFURBISHED C-ARMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA REFURBISHED C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA REFURBISHED C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA REFURBISHED C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA REFURBISHED C-ARMS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA REFURBISHED C-ARMS MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA REFURBISHED C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA REFURBISHED C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA REFURBISHED C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA REFURBISHED C-ARMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA REFURBISHED C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA REFURBISHED C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA REFURBISHED C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA REFURBISHED C-ARMS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA REFURBISHED C-ARMS MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA REFURBISHED C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA REFURBISHED C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA REFURBISHED C-ARMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA REFURBISHED C-ARMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA REFURBISHED C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA REFURBISHED C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA REFURBISHED C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA REFURBISHED C-ARMS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA REFURBISHED C-ARMS MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA REFURBISHED C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA REFURBISHED C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE REFURBISHED C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE REFURBISHED C-ARMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE REFURBISHED C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE REFURBISHED C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE REFURBISHED C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE REFURBISHED C-ARMS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE REFURBISHED C-ARMS MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE REFURBISHED C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE REFURBISHED C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST REFURBISHED C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST REFURBISHED C-ARMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST REFURBISHED C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST REFURBISHED C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST REFURBISHED C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST REFURBISHED C-ARMS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST REFURBISHED C-ARMS MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST REFURBISHED C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST REFURBISHED C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA REFURBISHED C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA REFURBISHED C-ARMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA REFURBISHED C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA REFURBISHED C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA REFURBISHED C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA REFURBISHED C-ARMS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA REFURBISHED C-ARMS MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA REFURBISHED C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA REFURBISHED C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC REFURBISHED C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC REFURBISHED C-ARMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC REFURBISHED C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC REFURBISHED C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC REFURBISHED C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC REFURBISHED C-ARMS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC REFURBISHED C-ARMS MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC REFURBISHED C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC REFURBISHED C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN REFURBISHED C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN REFURBISHED C-ARMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. ASEAN REFURBISHED C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN REFURBISHED C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN REFURBISHED C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN REFURBISHED C-ARMS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN REFURBISHED C-ARMS MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN REFURBISHED C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN REFURBISHED C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 162. GCC REFURBISHED C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. GCC REFURBISHED C-ARMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. GCC REFURBISHED C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. GCC REFURBISHED C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 166. GCC REFURBISHED C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. GCC REFURBISHED C-ARMS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 168. GCC REFURBISHED C-ARMS MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 169. GCC REFURBISHED C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. GCC REFURBISHED C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPEAN UNION REFURBISHED C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPEAN UNION REFURBISHED C-ARMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPEAN UNION REFURBISHED C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION REFURBISHED C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION REFURBISHED C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION REFURBISHED C-ARMS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION REFURBISHED C-ARMS MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION REFURBISHED C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION REFURBISHED C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 180. BRICS REFURBISHED C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. BRICS REFURBISHED C-ARMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. BRICS REFURBISHED C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS REFURBISHED C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS REFURBISHED C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS REFURBISHED C-ARMS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS REFURBISHED C-ARMS MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS REFURBISHED C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS REFURBISHED C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 189. G7 REFURBISHED C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. G7 REFURBISHED C-ARMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. G7 REFURBISHED C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. G7 REFURBISHED C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 193. G7 REFURBISHED C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. G7 REFURBISHED C-ARMS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 195. G7 REFURBISHED C-ARMS MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 196. G7 REFURBISHED C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. G7 REFURBISHED C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 198. NATO REFURBISHED C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. NATO REFURBISHED C-ARMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. NATO REFURBISHED C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. NATO REFURBISHED C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 202. NATO REFURBISHED C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. NATO REFURBISHED C-ARMS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 204. NATO REFURBISHED C-ARMS MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 205. NATO REFURBISHED C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. NATO REFURBISHED C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 207. GLOBAL REFURBISHED C-ARMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. UNITED STATES REFURBISHED C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 209. UNITED STATES REFURBISHED C-ARMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. UNITED STATES REFURBISHED C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED STATES REFURBISHED C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED STATES REFURBISHED C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED STATES REFURBISHED C-ARMS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED STATES REFURBISHED C-ARMS MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED STATES REFURBISHED C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED STATES REFURBISHED C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 217. CHINA REFURBISHED C-ARMS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 218. CHINA REFURBISHED C-ARMS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. CHINA REFURBISHED C-ARMS MARKET SIZE, BY DETECTOR TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. CHINA REFURBISHED C-ARMS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA REFURBISHED C-ARMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. CHINA REFURBISHED C-ARMS MARKET SIZE, BY CARDIOLOGY, 2018-2032 (USD MILLION)
  • TABLE 223. CHINA REFURBISHED C-ARMS MARKET SIZE, BY GENERAL SURGERY, 2018-2032 (USD MILLION)
  • TABLE 224. CHINA REFURBISHED C-ARMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. CHINA REFURBISHED C-ARMS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)